From numerous studies, it is known about the role of SGLT-2 inhibitors in reducing glycemia, cardio- and nephroprotection in patients with type 2 diabetes. SGLT-type 1 has been studied somewhat less, the management and activity of which may also be the key to compensating for type 2 diabetes, chronic diseases of the heart, kidneys and other organs and tissues. At the moment, inhibition of SGLT-1 in humans can only be achieved by using combined inhibitors of SGLT-1 /SGLT-2. Drugs with selective inhibition of SGLT-1 are actively studied in animals and in vitro studies. This review is devoted to the principles of the action of sodium-glucose cotransporter type 1, the effect of inhibition of SGLT-1 on pathological conditions, and also evaluated the prospects for the use of iSGLT-1 in humans.
| Mualliflar | Рахимова Гульнара Нишановна, Иброхимов Худойберди Хусанжон угли |
|---|---|
| Jurnal | Марказий Осиё эндокринологик журнали |
| Nashr sanasi | 2025-01-24 |
| Jild | 4 |
| Son | 3 |
| Til | Rus |
: ингибиторы натрий-глюкозного транспортера 1 типа, ингибиторы натрий глюкозного ко-транспортера 2 типа, сахарный диабет 2 типа, канаглифлозин, сотаглифлозин, мизаглифлозин, type 1 sodium-glucose transporter inhibitors, type 2 sodium glucose transporter inhibitors, type 2 diabetes mellitus, canagliflozin, sotagliflozin, misagliflozin, натрий-глюкоза ко-транспортери 1 тип ингибиторлари, натрий-глюкоза ко-транспортери 2 тип ингибиторлари, қандли диабет 2 тип, канаглифлозин, сотаглифлозин, мизаглифлозин
Endocrine ophthalmopathy is an autoimmune disease often associated with thyroid dysfunction. It affects the tissues of the orbit and periorbital structures, causing their edema and degenerative changes. One of the most…
Relevance. Type 2 diabetes mellitus (DM2) is a chronic disease that requires gradual intensification of therapy to control glycemia. Studies show that poor control lasts up to seven years, increasing the risk of…
Background. Research shows that excess weight negatively affects the development and progression of respiratory diseases. As the SARS-CoV-2 pandemic continues, it is important to understand how body mass index (BMI)…
Relevance. Graves' disease (GD) is a hereditary organ-specific autoimmune disorder. The incidence of GD in children has increased by 27.3-30.1% over the last 10-20 years, with a more pronounced rise in the last decade…
Currently, thyroid gland (TG) diseases with nodular formations are widespread, and due to ultrasound examination, it is possible to detect even the smallest nodules. The prevalence rate among the elderly population…
Objective. Obesity has become a global epidemic, affecting more than 600 million people worldwide. WHO reports that in 2022, 2.5 billion adults (18 years and older) were overweight. Of these, 890 million were living…
Diabetic retinopathy (DR) is recognised as the leading cause of blindness and low vision among people of working age. Diagnosis and grading of the disease is…
Background. Ultrasound-based thyroid nodule risk stratification, such as TIRADS, was introduced to reduce intervention in the “global epidemic” of “overdiagnosis” of thyroid cancer…
Purpose: To study the characteristics of diabetes occurring after contracting COVID-19. Methods: Hemostasis parameters, vitamin D levels, and beta cell-specific autoantibodies were tested in 70 patients with…
Relevance: Obesity is a significant global health issue requiring effective treatment methods. This study evaluates the impact of liraglutide, a glucagon-like peptide-1 (GLP-1) agonist, on non-diabetic obese patients…